Gilead fights back: CVS deal sends shares soaring
January 05, 2015 at 13:05 PM EST
Gilead Sciences' hepatitis C drugs, Sovaldi and Harvoni, will get exclusive coverage on several plans from CVS/Caremark, the pharmacy benefits manager said Monday, taking the opposite stance from competitor Express Scripts.
